Condition

Hemoglobinopathy clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Hemoglobinopathy clinical trials that are recruiting, at sites in 2 countries (most in United States (2), China (1)). By phase: Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Hemoglobinopathy clinical trials

StudyPhaseWhereStatusRegistered
Long-term follow-up after BEAM-101 treatment — Birmingham, Alabama and 16 other locations Recruiting Jan 28, 2026
Phase 1 testing of oral SNH-119014 in healthy adults Phase 1 Hefei, Anhui Recruiting Jul 25, 2025
Understanding red blood cell lifespan in sickle cell disease and hemoglobin disorders Early Phase 1 Bethesda, Maryland Recruiting Mar 15, 2024

All recruiting trials (3)

Related topics

Sickle Cell DiseaseThalassemia

Quick answers

How many Hemoglobinopathy clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.